Jacalin-capped silver nanoparticles minimize the dosage use of the anticancer drug, shikonin derivatives, against human chronic myeloid leukemia
Year: 2016
Type: article
Source: RSC Advances
DOI: 10.1039/c5ra27952f
Institutions: SASTRA University, Vidyasagar University, Bose Institute
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: closed
OpenAlex ID: W2302392374
